Join
Live feed
·
INSIDERFilingvia Quantisnow
Pear Therapeutics Inc. logo

SEC Form 4: Guiffre Christopherd T sold $22,080 worth of shares (19,540 units at $1.13), decreasing direct ownership by 39% to 29,960 units to satisfy tax liability

ByQuantisnow·Wall Street's wire, on your screen.
PEAR· Pear Therapeutics Inc.
Technology
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PEAR (Pear Therapeutics Inc.) and more on Quantisnow.